دورية أكاديمية
Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1-year double-blinded placebo-controlled randomized clinical trial.
| العنوان: | Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1-year double-blinded placebo-controlled randomized clinical trial. |
|---|---|
| المؤلفون: | Faveri M; Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil., Retamal-Valdes B; Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil., Mestnik MJ; Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil., de Figueiredo LC; Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil., Barão VAR; Department of Prosthodontics and Periodontology, Piracicaba Dental School, University of Campinas (UNICAMP), Piracicaba, Brazil., Souza JGS; Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil.; Dental Science School (Faculdade de Ciências Odontológicas-FCO), Montes, Claros, Brazil., Duarte PM; Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil.; Department of Periodontology, University of Florida College of Dentistry, Gainesville, Florida, USA., Feres M; Department of Periodontology, Dental Research Division, Guarulhos University, Guarulhos, São Paulo, Brazil.; The Forsyth Institute, Cambridge, Massachusetts, USA. |
| المصدر: | Journal of periodontology [J Periodontol] 2023 Apr; Vol. 94 (4), pp. 498-508. Date of Electronic Publication: 2023 Jan 30. |
| نوع المنشور: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: American Academy of Periodontology Country of Publication: United States NLM ID: 8000345 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-3670 (Electronic) Linking ISSN: 00223492 NLM ISO Abbreviation: J Periodontol Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Chicago] American Academy of Periodontology. |
| مواضيع طبية MeSH: | Dental Plaque*/microbiology , Periodontitis*/drug therapy, Humans ; Young Adult ; Adult ; Metronidazole/therapeutic use ; Amoxicillin/therapeutic use ; Combined Modality Therapy ; Anti-Bacterial Agents/therapeutic use ; Dental Scaling/methods ; Root Planing/methods ; DNA/therapeutic use ; Treatment Outcome |
| مستخلص: | Background: Despite the body of evidence supporting the clinical benefits of metronidazole (MTZ) and amoxicillin (AMX) in the treatment of young patients with periodontitis, the microbiological outcomes of this antibiotic protocol have been less explored. This study evaluated the microbiological effects of adjunctive MTZ+AMX in the treatment of young patients with periodontitis. Methods: Subjects with periodontitis Stages III or IV and ≤30 years old were randomly allocated to receive scaling and root planing (SRP) with placebo (n = 15) or with MTZ (400 mg) and AMX (500 mg) three times a day for 14 days (n = 15). Nine subgingival biofilm samples per subject (three samples from each probing depth (PD) category: ≤3, 4-6, and ≥7 mm) were collected at baseline and 3-, 6-, and 12-months post-treatment and individually analyzed for 40 bacterial species by checkerboard DNA-DNA hybridization. Results: Thirty subjects (15/group) with mean ages 27.6 ± 3.5 (control) and 26.8 ± 3.9 (test) were included. At 12 months post-therapy, the antibiotic group harbored lower proportions of red complex (1.3%) than the placebo group (12.5%) (p < 0.05). SRP + MTZ+AMX was more effective than mechanical treatment in reducing levels/proportions of several pathogens and increasing proportions of Actinomyces species (p < 0.05). Levels/proportions of Aggregatibacter actinomycetemcomitans were only reduced in the antibiotic group (p < 0.05). This group also exhibited greater reduction in the number of sites with PD ≥5 mm and higher percentage of subjects reaching the clinical end point for treatment (≤4 sites with PD ≥5 mm) than the control group (p < 0.05). Conclusion: SRP+MTZ+AMX allowed for establishing a long-term healthier subgingival biofilm community and periodontal clinical condition, than SRP only. (© 2022 American Academy of Periodontology.) |
| References: | Xajigeorgiou C, Sakellari D, Slini T, Baka A, Konstantinidis A. Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis. J Clin Periodontol. 2006;33:254-264. Guerrero A, Griffiths GS, Nibali L, et al. Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol. 2005;32:1096-1107. Akincibay H, Orsal SO, Sengün D, Tözüm TF. Systemic administration of doxycycline versus metronidazole plus amoxicillin in the treatment of localized aggressive periodontitis: a clinical and microbiologic study. Quintessence Int. 2008;39:e33-39. Mestnik MJ, Feres M, Figueiredo LC, Duarte PM, Lira EA, Faveri M. Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis. J Clin Periodontol. 2010;37:353-365. Mestnik MJ, Feres M, Figueiredo LC, et al. The effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized aggressive periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial. J Clin Periodontol. 2012;39:955-961. Yek EC, Cintan S, Topcuoglu N, Kulekci G, Issever H, Kantarci A. Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis. J Periodontol. 2010;81:964-974. Casarin RC, Peloso Ribeiro ED, Sallum EA, Nociti FH, Jr, Gonçalves RB, Casati MZ. The combination of amoxicillin and metronidazole improves clinical and microbiologic results of one-stage, full-mouth, ultrasonic debridement in aggressive periodontitis treatment. J Periodontol. 2012;83:988-998. Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. J Clin Periodontol. 2012;39:284-294. Taiete T, Casati MZ, Ribeiro Édel P, Sallum EA, Nociti Júnior FH, Casarin RC. Amoxicillin/metronidazole associated with nonsurgical therapy did not promote additional benefits in immunologic parameters in generalized aggressive periodontitis: a randomized controlled clinical trial. Quintessence Int. 2016;47:281-292. Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Periodontol. 2018;89(1):S173-s182. Suppl. Sgolastra F, Petrucci A, Gatto R, Monaco A. Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis. J Periodontol. 2012;83:731-743. Keestra JA, Grosjean I, Coucke W, Quirynen M, Teughels W. Non-surgical periodontal therapy with systemic antibiotics in patients with untreated aggressive periodontitis: a systematic review and meta-analysis. J Periodontal Res. 2015;50:689-706. Rabelo CC, Feres M, Gonçalves C, et al. Systemic antibiotics in the treatment of aggressive periodontitis. A systematic review and a Bayesian Network meta-analysis. J Clin Periodontol. 2015;42:647-657. Mendes CL, Assis P, Annibal H, et al. Metronidazole and amoxicillin association in aggressive periodontitis: a systematic review and meta-analysis. Saudi Dent J. 2020;32:269-275. Teughels W, Feres M, Oud V, Martín C, Matesanz P, Herrera D. Adjunctive effect of systemic antimicrobials in periodontitis therapy: a systematic review and meta-analysis. J Clin Periodontol. 2020;47:257-281. Suppl. 22. Silva-Senem MX, Heller D, Varela VM, Torres MC, Feres-Filho EJ, Colombo AP. Clinical and microbiological effects of systemic antimicrobials combined to an anti-infective mechanical debridement for the management of aggressive periodontitis: a 12-month randomized controlled trial. J Clin Periodontol. 2013;40:242-251. Feres M, Retamal-Valdes B, Fermiano D, et al. Microbiome changes in young periodontitis patients treated with adjunctive metronidazole and amoxicillin. J Periodontol. 2020. Feres M, Gursky LC, Faveri M, Tsuzuki CO, Figueiredo LC. Clinical and microbiological benefits of strict supragingival plaque control as part of the active phase of periodontal therapy. J Clin Periodontol. 2009;36:857-867. Socransky SS, Haffajee AD, Cugini MA, Smith C. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25:134-144. Socransky SS, Smith C, Martin L, Paster BJ, Dewhirst FE, Levin AE. Checkerboard” DNA-DNA hybridization. Biotechniques. 1994;17:788-792. Socransky SS, Haffajee AD, Smith C, Dibart S. Relation of counts of microbial species to clinical status at the sampled site. J Clin Periodontol. 1991;18:766-775. Feres M, Retamal-Valdes B, Faveri M, et al. Proposal of a clinical endpoint for periodontal trials: the treat-to-target approach. J Int Acad Periodontol. 2020;22:41-53. Rosier BT, Marsh PD, Mira A. Resilience of the oral microbiota in health: mechanisms that prevent dysbiosis. J Dent Res. 2018;97:371-380. Feres M, Retamal-Valdes B, Gonçalves C, Cristina Figueiredo L, Teles F. Did omics change periodontal therapy? Periodontol. 2000;85:182-209. 2021. Faveri M, Figueiredo LC, Duarte PM, Mestnik MJ, Mayer MP, Feres M. Microbiological profile of untreated subjects with localized aggressive periodontitis. J Clin Periodontol. 2009;36:739-749. Velsko IM, Harrison P, Chalmers N, et al. Grade C molar-incisor pattern periodontitis subgingival microbial profile before and after treatment. J Oral Microbiol. 2020;12:1814674. Montenegro SCL, Retamal-Valdes B, Bueno-Silva B, et al. Do patients with aggressive and chronic periodontitis exhibit specific differences in the subgingival microbial composition? A systematic review. J Periodontol. 2020;91:1503-1520. Renvert S, Wikström M, Dahlén G, Slots J, Egelberg J. Effect of root debridement on the elimination of Actinobacillus actinomycetemcomitans and Bacteroides gingivalis from periodontal pockets. J Clin Periodontol. 1990;17:345-350. Takamatsu N, Yano K, He T, Umeda M, Ishikawa I. Effect of initial periodontal therapy on the frequency of detecting Bacteroides forsythus, Porphyromonas gingivalis, and Actinobacillus actinomycetemcomitans. J Periodontol. 1999;70:574-580. Mombelli A, Schmid B, Rutar A, Lang NP. Persistence patterns of Porphyromonas gingivalis, Prevotella intermedia/nigrescens, and Actinobacillus actinomyetemcomitans after mechanical therapy of periodontal disease. J Periodontol. 2000;71:14-21. Van Winkelhoff AJ, Rodenburg JP, Goené RJ, Abbas F, Winkel EG, de Graaff J. Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis. J Clin Periodontol. 1989;16:128-131. Pavicić MJ, van Winkelhoff AJ, de Graaff J. In vitro susceptibilities of Actinobacillus actinomycetemcomitans to a number of antimicrobial combinations. Antimicrob Agents Chemother. 1992;36:2634-2638. Pavicić MJ, van Winkelhoff AJ, Pavicić-Temming YA, de Graaff J. Amoxycillin causes an enhanced uptake of metronidazole in Actinobacillus actinomycetemcomitans: a mechanism of synergy. J Antimicrob Chemother. 1994;34:1047-1050. Guerrero A, Nibali L, Lambertenghi R, et al. Impact of baseline microbiological status on clinical outcomes in generalized aggressive periodontitis patients treated with or without adjunctive amoxicillin and metronidazole: an exploratory analysis from a randomized controlled clinical trial. J Clin Periodontol. 2014;41:1080-1089. Nibali L, Koidou VP, Hamborg T, Donos N. Empirical or microbiologically guided systemic antimicrobials as adjuncts to non-surgical periodontal therapy? A systematic review. J Clin Periodontol. 2019;46:999-1012. Soares GM, Mendes JA, Silva MP, et al. Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a secondary analysis of microbiological results from a randomized clinical trial. J Clin Periodontol. 2014;41:366-376. Tamashiro NS, Duarte PM, Miranda TS, et al. Amoxicillin plus metronidazole therapy for patients with periodontitis and Type 2 diabetes: a 2-year randomized controlled trial. J Dent Res. 2016;95:829-836. Matarazzo F, Figueiredo LC, Cruz SE, Faveri M, Feres M. Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study. J Clin Periodontol. 2008;35:885-896. |
| فهرسة مساهمة: | Keywords: amoxicillin; dental scaling; metronidazole; microbiology; periodontitis; root planing; young adult |
| المشرفين على المادة: | 140QMO216E (Metronidazole) 804826J2HU (Amoxicillin) 0 (Anti-Bacterial Agents) 9007-49-2 (DNA) |
| تواريخ الأحداث: | Date Created: 20220723 Date Completed: 20230426 Latest Revision: 20230620 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1002/JPER.21-0171 |
| PMID: | 35869939 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 1943-3670 |
|---|---|
| DOI: | 10.1002/JPER.21-0171 |